165 related articles for article (PubMed ID: 35600403)
1. Long-Term Clinical Outcomes in Treatment-Naïve Patients With Orbital Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma: A Single-Center Study.
Min GJ; Kim SE; Kim TY; Jeon YW; O JH; Choi BO; Park G; Yang SW; Cho SG
Front Oncol; 2022; 12():769530. PubMed ID: 35600403
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Selection and Long-term Clinical Outcomes Between Chemotherapy and Radiotherapy as Primary Therapeutic Modality for Ocular Adnexal MALT Lymphoma.
Jeon YW; Yang HJ; Choi BO; Jung SE; Park KS; O JH; Yang SW; Cho SG
EClinicalMedicine; 2018; 4-5():32-42. PubMed ID: 31193655
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study.
Liang Y; Fu RY; Liu XL; Liu XD; Piao YS; Ma JM; Wang L
Cancer Med; 2023 Feb; 12(3):2514-2523. PubMed ID: 35906828
[TBL] [Abstract][Full Text] [Related]
4. Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study.
Kim SY; Yang SW; Lee WS; Yang JW; Oh SY; Ahn HB; Yang DH; Park SK; Chang JH; Kim HJ; Lee MJ; Cho SG
Oncotarget; 2017 Sep; 8(40):68583-68590. PubMed ID: 28978139
[TBL] [Abstract][Full Text] [Related]
5. [Treatment and prognosis of primary ocular adnexal extranodal marginal zone mucosa-associated lymphoid tissue lymphoma: a report from a single center].
Li X; Ye J; Yang L; Wei LQ; Cong J; Yao N; Yang J; Wang JW
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):209-214. PubMed ID: 35405778
[No Abstract] [Full Text] [Related]
6. Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review.
Chung HU; Son JH
J Yeungnam Med Sci; 2022 Jan; 39(1):3-11. PubMed ID: 34521183
[TBL] [Abstract][Full Text] [Related]
7. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy.
Ferreri AJ; Dolcetti R; Du MQ; Doglioni C; Resti AG; Politi LS; De Conciliis C; Radford J; Bertoni F; Zucca E; Cavalli F; Ponzoni M
Ann Oncol; 2008 May; 19(5):835-46. PubMed ID: 17986622
[TBL] [Abstract][Full Text] [Related]
8. Relapse in patients with limited-stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow-up of a phase 2 study.
Kim SY; Lee WS; Oh SY; Yang DH; Kim HJ; Park SK; Yang JW; Yang SW; Cho SG
Cancer Med; 2022 Jul; 11(14):2817-2823. PubMed ID: 35277938
[TBL] [Abstract][Full Text] [Related]
9. Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a single center experience of 32 patients from China.
Li Y; Wu FT; Wang L; Liang JH; Zhu HY; Wu JZ; Wu W; Xia Y; Fan L; Liu H; Zhang S; Zhang ZH; Li JY; Xu W
Int J Clin Exp Pathol; 2018; 11(3):1520-1528. PubMed ID: 31938249
[TBL] [Abstract][Full Text] [Related]
10. Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim SE; Yang HJ; Yang SW
BMC Ophthalmol; 2020 Jan; 20(1):24. PubMed ID: 31931766
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG
Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439
[TBL] [Abstract][Full Text] [Related]
12. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
13. Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.
Oh SY; Kim WS; Kang HJ; Lee JH; Huh SJ; Kim SJ; Yoon DH; Hong JY; Lee WS; Kim HJ; Won JH; Park BB; Lee SI; Suh C
Ann Hematol; 2018 Oct; 97(10):1851-1857. PubMed ID: 29947974
[TBL] [Abstract][Full Text] [Related]
14. Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas.
Park HL; O JH; Park SY; Jung SE; Park G; Choi BO; Kim SH; Jeon YW; Cho SG; Yang SW;
EJNMMI Res; 2019 Nov; 9(1):99. PubMed ID: 31754896
[TBL] [Abstract][Full Text] [Related]
15. Is it Worthwhile to Undergo the Extended Stage Assessment in Orbital and Ocular Adnexal MALT Lymphoma with Symptoms Limited to the Ocular Adnexa?
Park S; Lee GW; Hyun MS; Lee KH; Koh SA; Kim MK
Indian J Hematol Blood Transfus; 2022 Jan; 38(1):24-30. PubMed ID: 35125709
[TBL] [Abstract][Full Text] [Related]
16. Clinical analysis of ocular adnexal mucosa-associated lymphoid tissue lymphoma with IgG4-related ophthalmic disease.
Yoon J; Kim KJ; Sa HS
Orbit; 2022 Oct; 41(5):551-557. PubMed ID: 34369286
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
18. Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.
Smiljanic M; Milosevic R; Antic D; Andjelic B; Djurasinovic V; Todorovic M; Bila J; Bogdanovic A; Mihaljevic B
Med Oncol; 2013 Dec; 30(4):722. PubMed ID: 24026660
[TBL] [Abstract][Full Text] [Related]
19. Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML).
Jung SK; Paik JS; Jung SE; Park G; Choi BO; Oh JK; Park YG; Yang SW; Cho SG
Ann Hematol; 2015 Jul; 94(7):1185-93. PubMed ID: 25728714
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.
Park HH; Lee SW; Sung SY; Choi BO
Radiat Oncol J; 2017 Sep; 35(3):249-256. PubMed ID: 29037024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
